Compounds having a certain benzoxazine ring system and their precursors are disclosed which are useful for enhancing synaptic responses mediated by AMPA receptors. Also disclosed are methods for preparing such compounds, and methods for their use in treating subjects suffering from impaired nervous or intellectual functioning due to deficiencies in the number of excitatory synapses or in the number of AMPA receptors. The invention compounds can also be used for the treatment of non-impaired subjects for enhancing performance in sensory-motor and cognitive tasks which depend on brain networks utilizing AMPA receptors and for improving memory encoding.
揭示了具有特定苯并噁嗪环系统及其前体的化合物,这些化合物对通过
AMPA受体介导的突触响应有益。还公开了制备此类化合物的方法,以及用于治疗因兴奋性突触数量不足或
AMPA受体数量不足而导致神经或智力功能受损的受试者的方法。这些发明化合物还可用于治疗非受损受试者,以增强依赖
AMPA受体的大脑网络执行感觉运动和认知任务的性能,并改善记忆编码。